Clinical Trials on CD22 Positive in United Kingdom
Total 2303 results
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Lymphoma | CD20 Positive | Lymphocytic NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Mantle Cell Lymphoma | CCND1 Positive | CCND2 Positive | CCND3 Positive | CD20 Positive | Refractory Mantle Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | CD22 PositiveUnited States
-
University of OxfordUniversity of Cape Town; Mothers2MothersCompleted
-
Loughborough UniversityUK Sport, 40 Bernard Street, London, WC1N 1STCompletedPositive Doping Tests in SportsUnited Kingdom
-
Conjupro Biotherapeutics, Inc.SuspendedCD20 Positive Non Hodgkin LymphomaUnited States
-
Imperial College LondonHammersmith Hospitals NHS TrustCompletedStaphylococcal Infections | Gram-positive Bacterial InfectionsUnited Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); ADC Therapeutics S.A.RecruitingRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Philadelphia Chromosome Positive | Blasts 5 Percent or More of Bone Marrow Nucleated Cells | CD22 PositiveUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Blasts More Than 5 Percent of Bone Marrow Nucleated Cells | B Acute Lymphoblastic Leukemia With t(9;22)(q34... and other conditionsUnited States
-
Mentrik Biotech, LLCUnknownPreviously Treated CD20+ B-cell MalignanciesUnited States
-
University of OxfordUniversiti Putra Malaysia; University of Cape Town; Ateneo de Manila University; Health for Youth Association, Moldova and other collaboratorsCompletedChild Maltreatment | Positive ParentingUnited Kingdom
-
Swansea UniversityCompletedControl Condition | Positive Communication (Primary) | Negative CommunicationUnited Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | CD20 Positive | Refractory Mantle Cell Lymphoma | Blastoid Variant Mantle Cell Lymphoma | CCND1 Protein Overexpression | CD5 Positive | FCER2 Negative | Pleomorphic Variant Mantle Cell Lymphoma | t(11;14)(q13;q32)United States
-
Destiny Pharma PlcCompletedStaphylococcal InfectionUnited Kingdom
-
University Hospitals Coventry and Warwickshire...CompletedHead and Neck Position for IntubationUnited Kingdom
-
Nabi BiopharmaceuticalsPublic Health EnglandCompletedStaphylococcal InfectionsUnited Kingdom
-
GlaxoSmithKlineCompletedTuberculosisUnited Kingdom
-
Destiny Pharma PlcCompletedStaphylococcus Aureus InfectionUnited Kingdom
-
University of OxfordCompletedTuberculosisUnited Kingdom
-
Barts & The London NHS TrustNHS Research and DevelopmentUnknownTuberculosisUnited Kingdom
-
St George's, University of LondonUniversity of Nottingham; Medical Research Council; Public Health EnglandRecruitingStreptococcus Agalactiae InfectionUnited Kingdom
-
University of EdinburghNHS LothianCompleted
-
St George's Healthcare NHS TrustUnknownTuberculosisUnited Kingdom
-
University of OxfordCompletedTuberculosisUnited Kingdom
-
University of OxfordCompletedTuberculosisUnited Kingdom
-
Barts & The London NHS TrustImperial College London; Wellcome Trust; University of Cape Town; Newham Chest... and other collaboratorsCompleted
-
Liverpool School of Tropical MedicineUniversity of OxfordRecruiting
-
University of OxfordMason Medical Research TrustCompletedPneumococcal DiseaseUnited Kingdom
-
Queen Mary University of LondonHoffmann-La Roche; Asan Medical Center; Kliniken Essen-Mitte; MedSIRActive, not recruitingBreast Cancer | Estrogen Receptor-positive Breast CancerUnited Kingdom
-
University of OxfordCompleted
-
St George's, University of LondonNovartis Vaccines; Statens Serum Institut; European UnionTerminatedTuberculosisUnited Kingdom
-
University of OxfordCompleted
-
University of NottinghamUnknownProne Position | Cardiac Output | Liver CirculationUnited Kingdom
-
AstraZenecaQuotient SciencesCompletedER-positive, HER2-negative Breast CancerUnited Kingdom
-
University of OxfordCompletedA Study of 2 Doses of a New TB Vaccine, MVA85A, in Healthy Volunteers Previously Vaccinated With BCGTuberculosisUnited Kingdom
-
University of OxfordCompleted
-
University of SussexUniversity of California, San Francisco; Brighton & Sussex Medical School; Sylff...CompletedStress | Anxiety | Depressive Symptoms | Positive Affect | Sleep-Related Impairment | Mental Wellbeing | Negative AffectUnited Kingdom
-
University of OxfordCompleted
-
University of OxfordWellcome Trust; St George's, University of LondonCompleted
-
University of OxfordCompletedTuberculosisUnited Kingdom
-
University of OxfordCompleted
-
University College, LondonPublic Health EnglandCompletedTuberculosisUnited Kingdom
-
Queen Mary University of LondonUniversity College, London; Public Health EnglandCompletedLatent TuberculosisUnited Kingdom
-
King's College LondonGuy's and St Thomas' NHS Foundation Trust; Brighton and Sussex University Hospitals...Recruiting
-
St George's, University of LondonUnknownTuberculosis (TB)United Kingdom
-
Helen ReynoldsLiverpool University Hospitals NHS Foundation TrustCompleted
-
BioInvent International ABActive, not recruitingHER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | HER2-positive Metastatic Breast CancerSpain, United Kingdom, Germany
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedCD20-positive B-cell Non-Hodgkin LymphomaUnited States, France
-
GlaxoSmithKlineRecruitingTuberculosisUnited Kingdom, Netherlands
-
Imperial College Healthcare NHS TrustBarts & The London NHS Trust; Royal Free Hospital NHS Foundation Trust; University... and other collaboratorsActive, not recruiting